Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma
- PMID: 17656111
- DOI: 10.1016/j.biologicals.2007.03.002
Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma
Abstract
Large-pool solvent/detergent (SD) plasma for transfusion exhibits reduced alpha 2-antiplasmin (alpha2-AP; SERPINF2) functional activity. The reason for the loss of alpha2-AP has not been described and could be due to the SD incubation itself and/or to the processing steps implemented to remove the solvent and the detergent. We have studied alpha2-AP activity during six down-scale preparations of plasma virally-inactivated by 1% (v/v) TnBP combined with two different non-ionic detergents, either 1% Triton X-100 or 1% Triton X-45, at 31 degrees C for 4h. The SD-treated plasmas were then extracted with 7.5% (v/v) soybean oil, centrifuged at 3800 x g for 30 min, and subjected to hydrophobic interaction chromatography (HIC) to remove the SD agents. Control runs without TnBP and Triton were performed to evidence possible impacts of each process step on alpha2-AP activity. TnBP, Triton X-100, and Triton X-45 were measured at all stages of the processes to evaluate potential interferences with the alpha2-AP assay. Alpha 2-AP activity was about 10% that of starting plasma after 1% TnBP-1% Triton X-100 incubation and about 50% after oil extractions, centrifugation, and HIC. By contrast about 73% of the antiplasmin activity was found after the incubation with 1% TnBP and 1% Triton X-45, 88% after removal of the SD agents by oil extractions, 90% after centrifugation and 92% after HIC. The control runs performed without SD agents showed that the process steps did not affect the alpha2-AP activity. In conclusion, the agent altering alpha2-AP activity in SD-plasma is Triton X-100. The choice of detergents for the SD viral inactivation of therapeutic plasma fractions used in patients at risk of fibrinolysis should consider the impact on alpha2-AP activity.
Similar articles
-
A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.Vox Sang. 2006 Jul;91(1):56-62. doi: 10.1111/j.1423-0410.2006.00772.x. Vox Sang. 2006. PMID: 16756602
-
A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.Transfusion. 2006 Dec;46(12):2100-8. doi: 10.1111/j.1537-2995.2006.01035.x. Transfusion. 2006. PMID: 17176321
-
Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents.Anal Biochem. 2009 Jun 1;389(1):69-73. doi: 10.1016/j.ab.2009.03.016. Epub 2009 Mar 19. Anal Biochem. 2009. PMID: 19303391
-
[Virus inactivated plasma].Infusionsther Transfusionsmed. 1994 Aug;21 Suppl 1:73-6. Infusionsther Transfusionsmed. 1994. PMID: 8000259 Review. German.
-
[Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure)].Infusionsther Transfusionsmed. 1994 Aug;21 Suppl 1:77-9. Infusionsther Transfusionsmed. 1994. PMID: 8000260 Review. German.
Cited by
-
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.Blood Transfus. 2016 Jul;14(4):287-386. doi: 10.2450/2016.0065-16. Blood Transfus. 2016. PMID: 27403740 Free PMC article. Review.
-
TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.PLoS One. 2015 Feb 6;10(2):e0117800. doi: 10.1371/journal.pone.0117800. eCollection 2015. PLoS One. 2015. PMID: 25658612 Free PMC article.
-
The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma.Transfus Med Hemother. 2011;38(1):65-70. doi: 10.1159/000323552. Epub 2011 Jan 17. Transfus Med Hemother. 2011. PMID: 21779207 Free PMC article.
-
Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay.J Thromb Haemost. 2019 Jan;17(1):195-205. doi: 10.1111/jth.14338. Epub 2018 Dec 13. J Thromb Haemost. 2019. PMID: 30451372 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous